Operating Lease, Liability in USD of EAGLE PHARMACEUTICALS, INC. from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
EAGLE PHARMACEUTICALS, INC. quarterly Operating Lease, Liability history and change rate from Q4 2019 to Q2 2023.
  • EAGLE PHARMACEUTICALS, INC. Operating Lease, Liability for the quarter ending 30 Jun 2023 was $2.26M, a 39.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

EAGLE PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $2.26M -$1.47M -39.4% 30 Jun 2023 10-Q/A 09 Aug 2023
Q1 2023 $2.64M -$1.26M -32.3% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $3.04M -$1.17M -27.8% 31 Dec 2022 10-K 23 Mar 2023
Q3 2022 $3.38M -$865K -20.4% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $3.73M -$802K -17.7% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $3.9M -$912K -19% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $4.21M -$869K -17.1% 31 Dec 2021 10-K 08 Mar 2022
Q3 2021 $4.25M +$285K +7.19% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $4.53M 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $4.81M 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $5.08M +$981K +23.9% 31 Dec 2020 10-K 05 Mar 2021
Q3 2020 $3.96M 30 Sep 2020 10-Q 02 Nov 2020
Q4 2019 $4.1M 31 Dec 2019 10-Q 02 Nov 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.